US Patent Issued to Madrigal Pharmaceuticals on June 30 for "Methods for treating a fatty liver disease" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,575, issued on June 30, was assigned to Madrigal Pharmaceuticals Inc. (West Conshohocken, Pa.).

"Methods for treating a fatty liver disease" was invented by Rebecca Taub (Villanova, Pa.) and Dominic Labriola (Belmar, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a method of treating a fatty liver disease (e.g., non-alcoholic steatohepatitis (NASH)) in a human subject (e.g., an adult human subject) in need of such treatment (e.g., NASH/improving liver fibrosis) with 2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)oxy)phenyl)-3, 5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine-6-carbonitrile (resmetirom) ...